Astec LifeSciences Limited announced a challenging first quarter of the fiscal year 2025, with a consolidated total income of ₹70.3 crore compared to ₹144.6 crore in the same period last year. The company reported a substantial consolidated EBITDA loss of ₹45.3 crore, a stark contrast to the ₹4.8 crore profit recorded in Q1 FY24. The …